Cargando…

Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases

Studies investigating the effect of rituximab in children with nephrotic syndrome (NS) due to focal segmental glomerulosclerosis (FSGS) have reported conflicting results, with some concluding that patients may require additional immunosuppressive therapy to achieve and/or maintain long-term remissio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ambarsari, Cahyani Gita, Saraswati, Meilania, Laudza, Genta Syaifrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743143/ https://www.ncbi.nlm.nih.gov/pubmed/36518356 http://dx.doi.org/10.1159/000525776

Ejemplares similares

Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome
por: Al-Akash, Samhar, et al.
Publicado: (2005)

Early Use of Rituximab in Calcineurin Inhibitor–Refractory and Steroid-Resistant Nephrotic Syndrome
por: Sinha, Rajiv, et al.
Publicado: (2020)

Calcineurin Inhibitors With Reduced-Dose Steroids as First-Line Therapy for Focal Segmental Glomerulosclerosis
por: Chávez-Mendoza, Carlos Adrián, et al.
Publicado: (2018)

Permeability factors in nephrotic syndrome and focal segmental glomerulosclerosis
por: Savin, Virginia J., et al.
Publicado: (2012)

Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndrome
por: Sandoval, Diego, et al.
Publicado: (2017)

Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome
por: Dorresteijn, Eiske M., et al.
Publicado: (2008)

Comparison of three spot proteinuria measurements for pediatric nephrotic syndrome: based on the International pediatric Nephrology Association 2022 Guidelines
por: Ambarsari, Cahyani Gita, et al.
Publicado: (2023)

Rituximab treatment of adults with primary focal segmental glomerulosclerosis
por: Wang, Liuwei, et al.
Publicado: (2023)

Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis
por: Jauhal, Arenn, et al.
Publicado: (2022)

Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis
por: Park, Eujin, et al.
Publicado: (2020)

The Role of Rituximab in Focal Segmental Glomerulosclerosis–Update From Italy
por: Gauckler, Philipp, et al.
Publicado: (2022)

Mycophenolate Mofetil in the Treatment of Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children: A Meta-Analysis
por: Xiang, Xin, et al.
Publicado: (2021)

Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis
por: Xue, Cheng, et al.
Publicado: (2020)

Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi Survey
por: Floege, Jürgen, et al.
Publicado: (2022)

Population Pharmacokinetics of Rituximab in Pediatric Patients With Frequent-Relapsing or Steroid-Dependent Nephrotic Syndrome
por: Chen, Yewei, et al.
Publicado: (2021)

Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children
por: Fine, Richard N.
Publicado: (2007)

Successful treatment of adult-onset collapsing focal segmental glomerulosclerosis with rituximab
por: Ramachandran, Raja, et al.
Publicado: (2013)

Remission of post-transplant focal segmental glomerulosclerosis with angiotensin receptor blockers
por: Bansal, S. B., et al.
Publicado: (2017)

Efficacy of Mycophenolate Mofetil as a Remission Maintaining Agent in Idiopathic Childhood Nephrotic Syndrome
por: Nandi, M., et al.
Publicado: (2019)

Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2017)

Systematic Review and Meta-Analysis of Rituximab for Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children
por: Gao, Xia, et al.
Publicado: (2021)

A Rare Nephrotic Syndrome Related to Chronic Lymphocytic Leukemia: Focal Segmental Glomerulosclerosis
por: Karakus, Volkan, et al.
Publicado: (2022)

Rituximab treatment in adults with refractory minimal change disease or focal segmental glomerulosclerosis
por: Ren, Hong, et al.
Publicado: (2017)

Calcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the Literature
por: Laurin, Louis-Philippe, et al.
Publicado: (2017)

Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome
por: Sinha, A., et al.
Publicado: (2013)

Trends in the histopathology of childhood nephrotic syndrome in Ibadan Nigeria: preponderance of idiopathic focal segmental glomerulosclerosis
por: Asinobi, Adanze O., et al.
Publicado: (2015)

Case report: Focal segmental glomerulosclerosis and nephrotic syndrome following treatment with pamidronate for calcitriol toxicity
por: Dawson, Katherine Ann, et al.
Publicado: (2022)

Acute kidney failure and nephrotic syndrome secondary to COVID-19-associated focal segmental glomerulosclerosis
por: Shabaka, Amir, et al.
Publicado: (2022)

Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
por: Horinouchi, Tomoko, et al.
Publicado: (2018)

Treatment of Recurrent Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplant Recipients: Effect of Rituximab
por: Sethna, Christine, et al.
Publicado: (2011)

Rituximab for plasma exchange-dependent recurrent focal segmental glomerulosclerosis after renal transplantation
por: Deegens, Jeroen K. J., et al.
Publicado: (2008)

Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome
por: Basu, Biswanath, et al.
Publicado: (2020)

Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome: study protocol
por: Lugani, Francesca, et al.
Publicado: (2021)

Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol
por: Ravani, Pietro, et al.
Publicado: (2017)

Loss of Subpodocytic Space Predicts Poor Response to Tacrolimus in Steroid-Resistant Calcineurin Inhibitor-Naïve Adult-Onset Primary Focal Segmental Glomerulosclerosis
por: Agrawal, P., et al.
Publicado: (2019)

Adrenocorticotrophic Hormone−Induced Remission of Pediatric Post-transplantation Recurrent Focal Segmental Glomerulosclerosis
por: Raaijmakers, Anke, et al.
Publicado: (2019)

Steroid-responsive polyradiculopathy in association with focal segmental glomerulosclerosis
por: Chapman, Andrew R., et al.
Publicado: (2013)

Focal and Segmental Glomerulosclerosis and Membranous Nephropathy overlapping in a patient with Nephrotic Syndrome: a case report
por: da Silva, Crislaine Aparecida, et al.
Publicado: (2019)

Nephrotic Syndrome with Focal Segmental Glomerulosclerosis Induced by Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitor
por: Kakeshita, Kota, et al.
Publicado: (2020)

Successful Treatment of Nephrotic Syndrome Due to Collapsing Focal Segmental Glomerulosclerosis Accompanied by Acute Interstitial Nephritis
por: Shima, Hisato, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c4ec2eiuu78vfu1mi7obcu1mbf